Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
Status:
Active, not recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
This randomized phase I trial studies the side effects and best dose of Z-endoxifen
hydrochloride in treating participants who are undergoing breast surgery. Z-endoxifen
hydrochloride may treat or reduce the risk of breast cancer.